Unlocking the Future: Why Legend Biotech is the Must-Own Stock in Healthcare
Legend Biotech Corporation is becoming a significant player in the healthcare sector amidst financial strain and challenges like inflation and labor shortages. The U.S. healthcare technology market is expected to…
Major Health Shake-Up: White House Plans Massive Cuts While Pharma Giants Push Forward
The White House is planning cuts in federal health agencies, risking jobs and impacting drug approvals and medical research. Eli Lilly is advancing its GLP-1 weight loss drug, orforglipron, into…
From Immigrant to Innovator: How Andrea Pais is Revolutionizing Medical Diagnostics
Andrea Pais transitioned from a small-town upbringing in India to cofounding Novel Microdevices, a medical diagnostics startup, highlighting the potential of pursuing one's dreams against the odds. Her journey emphasizes…
Layoffs Loom for 300 Biotech Employees as Thermo Fisher Restructures
Thermo Fisher Scientific will lay off 300 employees by March 30 across Cambridge and Plainville. The layoffs come despite a reported 5% revenue increase for the fourth quarter of 2024.…
Frontier Medicines Restructures for Success: What You Need to Know
Frontier Medicines is streamlining its workforce to enhance operational efficiency and focus on high-impact therapies. Tough decisions, including layoffs, are deemed essential for maintaining a competitive edge in the biotech…
Valerio Therapeutics Shuts Down Trials: What It Means for Cancer Research
Valerio Therapeutics has suspended all clinical trials due to significant financial challenges. The company is pivoting towards early-stage projects while developing a single-chain antibody platform. Financial resources are projected to…
Unlocking Europe’s Biotech Future: A Game-Changing Initiative
The EU Biotech and Biomanufacturing Hub aims to boost Europe's innovative capacity in biotechnology. Stéphane Séjourne emphasizes biotechnology as key to industrial innovation and sustainable productivity. The initiative includes crucial…
Unlocking Potential: Why Legend Biotech Could Soar by 129% by 2025
Legend Biotech is poised for a significant stock surge, with projections indicating a potential 129% increase by 2025. The company has achieved impressive growth, notably a year-over-year increase in net…
Biotech Boom: 3 Must-Watch Stocks Making Waves Right Now
AbbVie is experiencing significant stock growth, reaching $183.90, driven by successful treatments like Humira and Skyrizi. Vertex Pharmaceuticals is gaining attention with shares at $461.68 and its innovative therapies for…
Evaxion Biotech’s Bold Move: $10.8 Million Offering to Propel Future Innovations
Evaxion Biotech raised $10.8 million through a recent public offering of nearly 4 million ADSs. The offering includes warrants for investors to buy up to 50% more ADSs at $2.71…